๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

222 A first-in-human, phase I trial of the anti-DLL4 antibody (OMP-21M18) targeting cancer stem cells (CSC) in patients with advanced solid tumors

โœ Scribed by D.C. Smith; P. Eisenberg; R. Stagg; G. Manikhas; A. Pavlovskiy; B. Sikic; A. Kapoun; S.E. Benner


Book ID
119602903
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
43 KB
Volume
8
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES